Discover the hidden dangers of excessive red chilli powder consumption. Learn how this common kitchen ingredient can trigger diarrhoea, heartburn, and even increase cancer risks in your daily diet.
Texfab Renaissance's SME IPO creates market frenzy with 35x subscription on day 2. Discover GMP surge, subscription status, price band details, and why investors are rushing.
Unlock the secrets of IPO investing! Learn how Fresh Issues and Offer for Sale work in the primary market and make smarter investment decisions.
Lenskart's highly anticipated IPO sees grey market premium skyrocketing ahead of issue opening. Get complete details on dates, price band, review, and what investors need to know.
Get the latest grey market premium updates for Orkla India IPO, Studds Accessories IPO, and Lenskart IPO. Discover which stocks are generating maximum investor buzz in today's primary market.
Orkla India's IPO makes explosive market debut with premium GMP. Discover subscription status, company analysis, and expert verdict on whether to invest in this FMCG giant.
Orkla India's highly anticipated IPO sees premium surge in grey market. Get complete analysis on price band, dates, and whether this FMCG giant is worth your investment.
SEBI revolutionizes IPO landscape for new-age companies, allowing founders to shed 'promoter' status. Discover how this regulatory shift benefits startups like Lenskart and transforms India's investment ecosystem.
The shocking death of NYPD Detective Alicia Stone reveals the deadly risks behind the popular Brazilian Butt Lift procedure. Discover why this cosmetic surgery has the highest mortality rate and what every potential patient must know.
As Lenskart prepares for its highly anticipated IPO, we compare it with market leader Titan Eyeplus across valuations, financial performance, store networks, and growth strategies in India's booming eyewear market.
Norwegian FMCG powerhouse Orkla considers Indian IPO, leveraging strong regional presence and impressive growth to challenge Tata Consumer in competitive market.
Orkla India's IPO creates massive buzz with premium GMP. Get complete details on dates, pricing, and expert analysis to make informed investment decisions.
Tata Capital shares demonstrate consistent performance since market debut. Expert analysis reveals whether investors should buy before today's crucial Q2 earnings announcement.
Lenskart's much-anticipated IPO filing reveals explosive growth, key risks, and financial metrics. Discover what makes this eyewear giant both promising and perilous for investors.
Studds Accessories gears up for its highly anticipated IPO with strong grey market activity. Discover the latest GMP, price band, issue size, and investment potential of this leading helmet manufacturer.
In a significant regulatory move, SEBI has halted Sterlite Electric's ₹1,250 crore IPO while approving five other public issues. Get the complete breakdown of approved IPOs and market implications.
Cryptocurrency markets witness unprecedented altcoin volatility while BlockDag's presale smashes records, attracting massive investor interest with 30,000x ROI potential. Discover why analysts are calling this the next big crypto opportunity.
Six Indian companies including Lenskart and Orkla India are gearing up for massive IPOs, aiming to raise over ₹1800 crore in what could be a game-changing moment for Indian markets.
Get ready for India's biggest eyewear revolution! Lenskart's massive ₹7,300 crore IPO opens October 31. Discover key dates, price band, financials, and expert insights before you invest in this vision care giant.
Breaking: Gaja Capital becomes India's pioneering private equity firm to file draft IPO papers via SEBI's confidential route, following successful exits from HDFC Life and SBI Life.
Delhi-based pharmaceutical support company SafeCure Services Ltd plans to raise up to ₹60 crore through IPO. Fresh issue of 48 lakh shares priced at ₹60-75 each. Learn key dates and details.
Everything Indian investors need to know about Orkla India's upcoming IPO - from subscription dates to critical risk factors. Get complete analysis before investing.
As Big Tech prepares to announce quarterly results, investors question whether the AI boom is sustainable growth or another market bubble waiting to burst.
Get complete insights into Lenskart's highly anticipated IPO for 2025. Discover the latest grey market premium, price band, lot size, subscription dates, and expert analysis on India's eyewear giant's market debut.
In a bold show of confidence, Lenskart promoters including Peyush Bansal have invested ₹25 crore to increase their stake, sending strong signals to investors before the company's anticipated public listing.
Discover how one NSE SME-listed company transformed early investors into millionaires with explosive 240% returns since IPO. Learn what makes this stock a market sensation.
Get exclusive insights into Lenskart's highly anticipated 2025 IPO, including expected price band, subscription dates, lot size details, and latest pre-IPO developments that every investor should know.
Lenskart founders Peyush Bansal and his wife Neha could earn over ₹825 crore profit by selling part of their stake in the company's upcoming IPO through Offer for Sale route. Get exclusive details about India's eyewear giant public listing.
Get all the essential information about Studds Accessories Limited's upcoming IPO, including price band, dates, lot size, and company fundamentals. Don't miss this helmet manufacturing giant's market debut!
Critical IPO lock-in expiry for 7 companies including Waaree Energies and SolarWorld Energy could trigger significant stock volatility. Expert analysis on what investors should expect.